Cargando…
Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?
Autor principal: | Garraud, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320683/ https://www.ncbi.nlm.nih.gov/pubmed/32631501 http://dx.doi.org/10.1016/j.transci.2020.102858 |
Ejemplares similares
-
A look-back at convalescent plasma to treat COVID-19
por: Garraud, Olivier, et al.
Publicado: (2021) -
Convalescent plasma to treat COVID-19: Following the Argentinian lead
por: Tiberghien, Pierre, et al.
Publicado: (2021) -
Convalescent Covid-19 plasma: Back-to-basics and ethics, and next steps
por: Garraud, O., et al.
Publicado: (2021) -
Convalescent plasma for administration of passive antibodies against viral agents
por: Di Minno, Giovanni, et al.
Publicado: (2020) -
Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2016)